| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.2207 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.3270 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4015 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4040 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4535 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4752 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4770 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4874 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4878 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4935 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.4983 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5076 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5093 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5270 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5272 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5372 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5521 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5681 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5693 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.5956 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6168 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6211 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6219 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6316 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6317 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6360 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6467 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6478 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6493 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6506 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6547 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6616 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6656 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6663 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6701 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6802 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6945 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.6990 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7057 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7065 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7087 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7159 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7242 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7247 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7269 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7338 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7359 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7401 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7448 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7520 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7582 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7584 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7596 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7759 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7794 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7798 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.7835 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8010 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8206 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8242 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8320 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8354 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8400 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8456 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8483 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8636 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8742 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8773 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8784 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8846 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.8865 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9042 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9100 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9160 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9201 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9232 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9253 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9307 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9410 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9484 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9501 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9520 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9695 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9726 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9733 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9736 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9747 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9775 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9867 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9893 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9947 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9965 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 0.9980 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0000 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0035 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0107 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0130 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0144 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0189 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0362 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0383 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0412 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0416 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0487 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0551 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0610 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0685 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0754 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0813 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0875 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0944 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.0967 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1002 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1006 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1029 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1150 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1231 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1236 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1258 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1263 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1308 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1369 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1455 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1524 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1680 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1809 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1916 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1956 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.1959 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2002 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2164 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2184 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2190 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2252 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2281 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2360 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2374 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2480 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2520 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2537 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2546 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2674 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2704 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2792 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.2890 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3372 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3409 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3525 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3532 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3548 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3563 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3574 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3713 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.3768 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4016 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4398 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4559 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4743 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4845 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.4954 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5071 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5340 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5366 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5393 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5537 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5544 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5630 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5681 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5819 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.5828 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.6192 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.7175 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.7668 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.7782 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.8421 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.8874 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.9351 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 1.9356 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.0500 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.0550 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.1017 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.2127 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.2431 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.3141 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.3165 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.5888 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | alpha-ketobutyrate | 2.8522 | scaled units | High-Dose | +23HR POST INFUSION |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|